WhatsApp Skip to main content

Dr. Harsh J Shah

How High Is Your GIST Risk? Size, Cells and Site

Last updated: 17-Nov-2026

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Dr Harsh Shah, stomach cancer surgeon, Ahmedabad

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Stomach Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience

In short

After a GIST is removed, the pathologist sorts it into a risk group: very low, low, intermediate or high. The group shows how likely the tumour is to come back.

Four findings make the group: the size of the tumour, how many cells are dividing, where in the gut it grew, and whether it burst open. A gene result can then move the decision up or down.

The risk group, not the stage, is what usually decides whether you need imatinib tablets after surgery, and for how long.

For the whole story of GIST, from the first test to imatinib and surgery, read our GIST treatment in Ahmedabad page. This post explains the risk group and stage written on your report.

Why does a GIST need a risk group at all?

Two GISTs that look alike on a scan can behave very differently. The risk group is how the team tells a tumour that will stay quiet from one that may return.

  • Once the tumour is out, the main question is whether any cells could have been left behind, or have already travelled.
  • A low group means the chance of return is small, so tablets can be spared and scans can be fewer.
  • A high group means the chance of return is real, so tablets after surgery and closer scans are advised.
  • The group also helps the family plan the next few years instead of guessing.

The group is final only after the whole tumour is studied, which is why it is written on the pathology report of the operation and not on the first biopsy. The tests that come before it are in our post on how a GIST is confirmed with CT, scope and biopsy.

Which four findings decide the risk group?

Size, the count of dividing cells, the site in the gut, and rupture. Each one must be written on a good report, and a missing one makes the group uncertain.

  • Size. The longest measurement of the whole tumour is used, taken from the fresh specimen. The size on the operation specimen counts more than the size on the scan.
  • Dividing cells. The pathologist counts cells caught in the act of dividing, in a fixed area of the slide, choosing the busiest spot. More dividing cells mean a faster-growing tumour.
  • Site. The stomach, small bowel, back passage and food pipe each behave differently, even at the same size.
  • Rupture. Whether the tumour burst or was torn before or during the operation.

Ask whether the count was given for a fixed area, because old reports used a different unit and the two cannot be swapped. A report that says only “malignant” or “benign” without these four details is not enough to plan tablets.

How are the risk groups worked out?

The four findings are read against a standard chart. The version most doctors use today treats a burst tumour as high risk straight away.

GIST risk groups in simple terms, and the usual next step
Risk groupWhat is usually foundUsual next step
Very lowUp to 2 cm, few dividing cells, not burstNo tablets; routine follow-up
Low2 to 5 cm, few dividing cells, not burstNo tablets; scans for some years
IntermediateA stomach tumour of 5 to 10 cm with few dividing cells, or a small one with a moderate countDecided one patient at a time; the gene result helps
HighOver 10 cm, or many dividing cells, or a burst tumour, or a small-bowel tumour of middle sizeImatinib after surgery is usually advised

The chart is a guide to the pattern. Your own group is set by the pathologist from your actual numbers, and Dr Shah reads it together with your scans and your gene result.

Why does the site of the tumour matter?

The same size and the same count are safer in the stomach than elsewhere. A tumour outside the stomach is placed in a higher group.

  • The stomach has the most favourable record. A tumour of middle size with few dividing cells there often needs no tablets.
  • The small bowel does worse at the same size, so a middle-sized tumour there is often treated as high risk.
  • The duodenum sits in between, though the size of the operation needed often decides the discussion first.
  • The rectum behaves worst even when small, so tablets are advised for almost any rectal GIST above the smallest group.
  • A GIST found outside the gut wall, in the fat of the belly, is treated like a small-bowel one at the least.

A first scan or scope that shows where the tumour started therefore matters. Our post on how the scope and endoscopic ultrasound assess a GIST explains how the layer and the site are read.

Why is a burst tumour always high risk?

Because a burst tumour can scatter cells inside the belly, where they settle on the lining and grow later. This risk is large enough to override every other finding.

  • Rupture includes bleeding from the tumour into the belly before surgery, and a tear during the operation or while taking the specimen out.
  • A biopsy needle that pierces the tumour and passes through the belly, and a piece-by-piece removal, are also counted.
  • An operation that leaves visible tumour behind is counted in the same way.
  • An ulcer on the inner lining of the stomach, or a tumour that touches the belly lining without a tear, is not rupture.

This is why a surgeon handles a GIST gently, without squeezing or pulling it with instruments, and removes it whole in a bag. Where possible the tumour is taken out intact, and the pathologist is told if anything went differently.

Can the gene result change your group?

Yes. The gene result is not part of the chart, but it can raise the decision or lower it, and it often changes which tablet is used.

  • A KIT exon 11 change with a small deletion at one spot returns sooner, so an intermediate tumour may be treated like a high one.
  • A KIT exon 9 change is seen mostly in the small bowel and needs a higher tablet dose if the disease spreads.
  • PDGFRA D842V tumours are slow and usually indolent, but imatinib does not work on them, so tablets after surgery are not used.
  • SDH-deficient tumours do not respond well to imatinib either, so the plan relies on surgery and long watching.

The meaning of each gene change is in our post on what your GIST gene report means.

Do you need tablets after surgery?

Very low and low groups do not need them. A high group usually does. An intermediate group is the one that needs a careful talk.

  • For a high-risk tumour, imatinib for about three years after surgery is the usual advice. It lowers the chance of return more than one year of tablets does.
  • Studies of an even longer course are now reported. Whether it suits you depends on your group, your gene result and how well you tolerate the tablet.
  • For an intermediate tumour, the gene result, the exact numbers and your own wishes are weighed.
  • For a very low or low tumour, tablets are not needed, and the effort goes into follow-up scans instead.

How surgery and tablets are put in order is explained in our post on surgery or imatinib first: how the order is set, and the studies behind the three-year course are in the key GIST studies and what is new.

What is staging, and how is it different?

Staging uses the common cancer system of tumour size, glands and spread. For GIST it is used for records more than for deciding treatment.

  • The stage is built from the size, whether lymph glands are involved, whether it has spread to other organs, and the dividing-cell count.
  • Glands are rarely involved in a GIST, so that part of the system adds little.
  • Early stages mean a small tumour with few dividing cells. Later stages mean a larger tumour with many dividing cells. The last stage means spread to glands or other organs.
  • Cancer registries and trials use the stage, but the tablet decision is taken on the risk group.

So do not be alarmed by a stage number alone. A stage and a risk group answer different questions, and the risk group is the one that guides your treatment.

What if you are on the edge between two groups?

Two calculators turn the same findings into a personal chance of staying free of GIST. They are used when a tumour sits close to a dividing line.

  • A chart from a large cancer centre gives a personal figure from size, count and site.
  • A second map, built from many hospitals together, shows the chance on a colour grid, so the team can read your exact point.
  • Neither counts rupture or the gene change fully, so they support the decision and do not replace it.
  • A tumour of 4.9 cm and one of 5.1 cm are not truly different, which is why these tools help near a boundary.

Before surgery, the group can only be estimated, since a needle biopsy samples only part of the tumour. The final group is set after the whole tumour is studied.

What should you ask about your report?

Five questions cover it. Ask them with the report in your hand.

  1. What is the exact size, and in how many places was it measured?
  2. What was the dividing-cell count, and for which area of the slide?
  3. Which part of the gut did it come from?
  4. Was the tumour intact when it was removed?
  5. Given all this, which risk group am I in, and does it change my tablets or my scans?

If any answer is missing, the report is not yet complete. Dr Shah will go through it with you and order what is missing, including a second look by the pathologist.

Frequently asked questions

What is a GIST risk group?

It is a score from four findings: tumour size, how many cells are dividing, the site in the gut, and whether the tumour burst. It sorts the tumour as very low, low, intermediate or high risk of coming back.

Is the risk group the same as the stage?

No. The stage describes size, glands and spread in the common cancer system. The risk group says how likely the tumour is to return, and it is the one that guides tablets after surgery.

Does high risk mean the GIST cannot be controlled?

No. High risk means the chance of return is real, so tablets and closer scans are advised. Many people in this group are treated and watched for years.

Will I need imatinib tablets after surgery?

Very low and low groups do not. A high group usually does, often for about three years. An intermediate group is decided one patient at a time, using the gene result.

Why does it matter where in the gut the tumour grew?

The same size and cell count are safer in the stomach than in the small bowel or the back passage. A tumour outside the stomach is placed in a higher group.

Why is a burst tumour always high risk?

A tumour that bursts can scatter cells into the belly, and these settle and grow later. That risk outweighs every other finding, so the group is high whatever the size.

What if my report does not show the dividing-cell count?

Then the risk group cannot be fixed. Ask the pathologist for the count over a fixed area of the slide, and for a second look if needed. Dr Shah can arrange this.

Related pages

For the full picture of GIST and its treatment, start at the GIST treatment in Ahmedabad page. For questions before you travel, call +91-63555-64601.

Where Dr Harsh Shah sees patients and operates

Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601

Operated for a GIST, and now the report says "intermediate" or "high risk"? Wondering whether you must take tablets for years? That word is not a verdict. It is a working score made from four findings, and it tells the team how closely to watch you and whether tablets will help. Dr Harsh Shah, a stomach cancer surgeon in Ahmedabad, goes through your risk group with you in plain words. Bring the report. You can call us or book by message. Call For Appointment Book on WhatsApp Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Get health updates from Dr Harsh Shah on WhatsApp

Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

Dr. Harsh J Shah
Dr Harsh Shah, Gastro, Cancer & Laparoscopic Surgeon, Ahmedabad
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.